Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.67%
1,094.77
-7.41
-0.67%
1,102.181,096.241,103.051,092.86
SIXC
Communications
SIXC
Communications
SIXC
-0.71%
611.88
-4.36
-0.71%
616.24616.24617.68611.01
SIXE
Energy
SIXE
Energy
SIXE
+0.72%
1,198.27
+8.55
+0.72%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.35%
1,748.98
+23.29
+1.35%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-1.21%
635.83
-7.79
-1.21%
643.62643.13643.17634.87
SIXR
Staples
SIXR
Staples
SIXR
+1.54%
842.57
+12.78
+1.54%
829.79832.32843.23832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.56%
214.59
+1.19
+0.56%
213.40213.40216.05213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.52%
3,137.40
-48.52
-1.52%
3,185.923,160.893,178.723,127.99
SIXU
Utilities
SIXU
Utilities
SIXU
+2.41%
930.82
+21.88
+2.41%
908.94912.57932.57912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.55%
1,470.76
-8.20
-0.55%
1,478.961,478.171,482.911,469.10
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.20%
2,376.55
-28.81
-1.20%
2,405.362,390.342,402.532,372.05
6C1:FRA
CytomX Therapeutics Inc
€3.86
-2.79%
(-0.11) 1D
Apr 23, 9:15:08 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6C1...
Open
€3.86
High
€3.86
Low
€3.86
Mkt. cap
960.91M
Avg. vol.
547.00
Volume
0.00
52-wk high
€6.97
52-wk low
€0.56
No. of employees
69
News stories
From sources across the web
About CytomX Therapeutics Inc
CEO-
Employees69
Founded2008
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytomx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
50.92M
18.66M
5.96M
663.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
18.87M
13.32M
15.30M
19.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.43M
6.62M
6.43M
6.26M
Operating expense
28.30M
19.94M
21.73M
25.80M
Total operating expenses
28.30M
19.94M
21.73M
25.80M
Operating income
22.62M
-1.29M
-15.77M
-25.13M
Other non operating income
-
-
-
-
EBT including unusual items
23.59M
-91.00K
-14.17M
-26.46M
EBT excluding unusual items
23.59M
-91.00K
-14.17M
-23.66M
Income tax expense
62.00K
63.00K
58.00K
54.00K
Effective tax rate
0.26%
-69.23%
-0.41%
-0.20%
Other operating expenses
-
-
-
-
Net income
23.52M
-154.00K
-14.23M
-26.51M
Net profit margin
46.20%
-0.83%
-238.62%
-3,998.49%
Earnings per share
0.27
-
-0.09
-0.22
Interest and investment income
955.00K
1.18M
1.59M
1.48M
Interest expense
-
-
-
-
Net interest expenses
955.00K
1.18M
1.59M
1.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
23.01M
-939.00K
-15.63M
-24.62M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more